logo

Upcoming facilities

At BEACON Pharmaceuticals, we are excited to introduce a multitude of upcoming facilities that will soon shape the future. Stay tuned for innovative advancements that will redefine healthcare excellence.

BEACON Cephalosporin Limited

Beacon Cephalosporin PLC is a prominent name in the pharmaceutical industry of Bangladesh. Established in 2021, the dedicated state-of-the-art facility is based in Bhaluka, Mymensingh. Spreading over 3 acres of land, the manufacturing facility has been designed and built with strict cGMP compliance. The building and facility are designed in accordance with EU GMP and USFDA guidance industry regulation. It has been already inspected by the EU member country in order to acquire the EU GMP certificate. The equipment's are highly technology based and fully automated system.

This state-of-the-art facility boasts the capacity to manufacture all ranges and forms of Cephalosporin drugs, including injections, oral tablets, capsules, and dry syrups.
Recognizing the complexity of the plant and prioritizing health and safety, we've implemented stringent protocols to ensure segregation and prevent cross-contamination with other generic drug manufacturing operations. This not only underscores our dedication to quality but also aligns with industry best practices.
Moreover, in our commitment to environmental responsibility, the facility is equipped with its own effluent treatment plant to minimize its impact on the surrounding environment.

BEACON Cephalosporin Limited
BEACON Cephalosporin Limited

Our upcoming facilities

Beacon Pharmaceuticals' upcoming facilities

Oncology FDA Facility
Cream Ointment Facility
API Plant
Our upcoming facilities
Our upcoming facilities